Stay updated on SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Sign up to get notified when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.

Latest updates to the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision indicator was updated from v3.5.2 to v3.5.3, signaling a minor update to the page's metadata.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page. No other content or functionality appears to be affected.SummaryDifference0.0%

- Check58 days agoChange Detected- Revision: v3.4.3 added; v3.4.2 removed.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision: v3.4.2 was added. The notice about government funding lapse was removed.SummaryDifference0.2%

- Check94 days agoChange DetectedAdded a government funding lapse notice with NIH Clinical Center operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.